3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione

C27H28N4O5 — CID 167715264

IUPAC3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione
SMILESO=C1CCC(N2Cc3cc(CN4CCCC5(CC4)OC(=O)Nc4ccccc45)ccc3C2=O)C(=O)N1
InChIInChI=1S/C27H28N4O5/c32-23-9-8-22(24(33)29-23)31-16-18-14-17(6-7-19(18)25(31)34)15-30-12-3-10-27(11-13-30)20-4-1-2-5-21(20)28-26(35)36-27/h1-2,4-7,14,22H,3,8-13,15-16H2,(H,28,35)(H,29,32,33)
InChIKeyGDJFFIHLSWSWPO-UHFFFAOYSA-N
MW488.54 g/mol
LogP2.89
Rot. Bonds3

About 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione

3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione (PubChem CID 167715264) has the molecular formula C27H28N4O5 and a molecular weight of 488.54 g/mol. Its IUPAC name is 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione.

Molecular Properties

Compound Name3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione
PubChem CID167715264
Molecular FormulaC27H28N4O5
Molecular Weight488.54 g/mol
Exact Mass488.21
IUPAC Name3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione
SMILESO=C1CCC(N2Cc3cc(CN4CCCC5(CC4)OC(=O)Nc4ccccc45)ccc3C2=O)C(=O)N1
InChIInChI=1S/C27H28N4O5/c32-23-9-8-22(24(33)29-23)31-16-18-14-17(6-7-19(18)25(31)34)15-30-12-3-10-27(11-13-30)20-4-1-2-5-21(20)28-26(35)36-27/h1-2,4-7,14,22H,3,8-13,15-16H2,(H,28,35)(H,29,32,33)
InChIKeyGDJFFIHLSWSWPO-UHFFFAOYSA-N
XLogP2.89
TPSA108.05 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500488.54
LogP ≤ 52.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione?
The IUPAC name of 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione (CID 167715264) is 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione.
What is the SMILES notation for 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione?
The canonical SMILES for 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione is O=C1CCC(N2Cc3cc(CN4CCCC5(CC4)OC(=O)Nc4ccccc45)ccc3C2=O)C(=O)N1.
What is the InChIKey of 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione?
The InChIKey is GDJFFIHLSWSWPO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H28N4O5/c32-23-9-8-22(24(33)29-23)31-16-18-14-17(6-7-19(18)25(31)34)15-30-12-3-10-27(11-13-30)20-4-1-2-5-21(20)28-26(35)36-27/h1-2,4-7,14,22H,3,8-13,15-16H2,(H,28,35)(H,29,32,33).
What are the key properties of 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione?
3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione has a molecular weight of 488.54 g/mol, XLogP of 2.89, 3 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-oxo-6-[(2-oxospiro[1H-3,1-benzoxazine-4,4'-azepane]-1'-yl)methyl]-1H-isoindol-2-yl]piperidine-2,6-dione is sourced from PubChem (CID 167715264), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).